Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1159/000535851
Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection.|https://dx.doi.org/10.3390/jcm13051331
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|https://dx.doi.org/10.1016/j.jhin.2024.03.001
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|https://dx.doi.org/10.1136/gutjnl-2023-331550
Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment.|https://dx.doi.org/10.1016/j.dld.2024.03.008
Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models.|https://dx.doi.org/10.1128/aem.00016-24
Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection.|https://dx.doi.org/10.3390/antib13020026
Management and Outcomes of Patients at a Specialty Clinic for Clostridioides difficile Infection.|https://dx.doi.org/10.1093/ofid/ofae153
Is shorter also better in the treatment of Clostridioides difficile infection?|https://dx.doi.org/10.1093/jac/dkae119
Machine Learning-based Prediction Models for C difficile Infection: A Systematic Review.|https://dx.doi.org/10.14309/ctg.0000000000000705
Derotational distal femur osteotomy with medial patellofemoral ligament reconstruction can get good outcomes in the treatment of recurrent patellar dislocation with excessive TT-TG and increased femoral anteversion.|https://dx.doi.org/10.3389/fsurg.2024.1392947
Clostridiodes difficile infection in inflammatory bowel disease: a clinical review.|https://dx.doi.org/10.1080/14787210.2024.2347955
Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on a case-by-case assessment of the benefit/risk ratio.|https://dx.doi.org/10.1053/j.gastro.2024.04.022
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study.|https://dx.doi.org/10.1016/j.micinf.2024.105341
Clostridioides difficile Colitis.|https://dx.doi.org/10.1016/j.suc.2023.11.005
